1. Home
  2. SONN vs MSPR Comparison

SONN vs MSPR Comparison

Compare SONN & MSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • MSPR
  • Stock Information
  • Founded
  • SONN N/A
  • MSPR 2014
  • Country
  • SONN United States
  • MSPR United States
  • Employees
  • SONN N/A
  • MSPR N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • MSPR
  • Sector
  • SONN Health Care
  • MSPR
  • Exchange
  • SONN Nasdaq
  • MSPR NYSE
  • Market Cap
  • SONN 4.6M
  • MSPR N/A
  • IPO Year
  • SONN N/A
  • MSPR N/A
  • Fundamental
  • Price
  • SONN $1.29
  • MSPR $1.90
  • Analyst Decision
  • SONN Strong Buy
  • MSPR
  • Analyst Count
  • SONN 2
  • MSPR 0
  • Target Price
  • SONN $38.00
  • MSPR N/A
  • AVG Volume (30 Days)
  • SONN 31.6K
  • MSPR 4.6M
  • Earning Date
  • SONN 05-16-2025
  • MSPR 05-19-2025
  • Dividend Yield
  • SONN N/A
  • MSPR N/A
  • EPS Growth
  • SONN N/A
  • MSPR N/A
  • EPS
  • SONN N/A
  • MSPR N/A
  • Revenue
  • SONN $1,000,000.00
  • MSPR $18,249,000.00
  • Revenue This Year
  • SONN $5,376.22
  • MSPR N/A
  • Revenue Next Year
  • SONN N/A
  • MSPR N/A
  • P/E Ratio
  • SONN N/A
  • MSPR N/A
  • Revenue Growth
  • SONN 674.14
  • MSPR 574.64
  • 52 Week Low
  • SONN $1.10
  • MSPR $1.10
  • 52 Week High
  • SONN $16.00
  • MSPR $22.25
  • Technical
  • Relative Strength Index (RSI)
  • SONN 45.29
  • MSPR N/A
  • Support Level
  • SONN $1.30
  • MSPR N/A
  • Resistance Level
  • SONN $1.37
  • MSPR N/A
  • Average True Range (ATR)
  • SONN 0.10
  • MSPR 0.00
  • MACD
  • SONN -0.01
  • MSPR 0.00
  • Stochastic Oscillator
  • SONN 22.58
  • MSPR 0.00

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Share on Social Networks: